- Home
- ANSS vs WST Comparison
ANSS vs WST Comparison
Compare ANSS & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANSS
- WST
- Stock Information
- Founded
- ANSS 1970
- WST 1923
- Country
- ANSS United States
- WST United States
- Employees
- ANSS N/A
- WST N/A
- Industry
- ANSS Computer Software: Prepackaged Software
- WST Medical/Dental Instruments
- Sector
- ANSS Technology
- WST Health Care
- Exchange
- ANSS Nasdaq
- WST Nasdaq
- Market Cap
- ANSS 32.3B
- WST 15.6B
- IPO Year
- ANSS 1996
- WST N/A
- Fundamental
- Price
- ANSS $374.30
- WST $210.79
- Analyst Decision
- ANSS Hold
- WST Buy
- Analyst Count
- ANSS 2
- WST 7
- Target Price
- ANSS $368.00
- WST $331.67
- AVG Volume (30 Days)
- ANSS 1.9M
- WST 623.5K
- Earning Date
- ANSS 07-30-2025
- WST 07-24-2025
- Dividend Yield
- ANSS N/A
- WST 0.40%
- EPS Growth
- ANSS 35.35
- WST N/A
- EPS
- ANSS 6.74
- WST 6.37
- Revenue
- ANSS $2,583,095,000.00
- WST $2,895,800,000.00
- Revenue This Year
- ANSS $11.48
- WST $3.38
- Revenue Next Year
- ANSS $10.05
- WST $5.82
- P/E Ratio
- ANSS $57.54
- WST $33.06
- Revenue Growth
- ANSS 15.98
- WST N/A
- 52 Week Low
- ANSS $275.06
- WST $187.43
- 52 Week High
- ANSS $395.49
- WST $352.33
- Technical
- Relative Strength Index (RSI)
- ANSS 62.41
- WST 38.17
- Support Level
- ANSS $346.87
- WST $219.46
- Resistance Level
- ANSS $395.00
- WST $226.03
- Average True Range (ATR)
- ANSS 7.40
- WST 6.31
- MACD
- ANSS 1.71
- WST -1.05
- Stochastic Oscillator
- ANSS 59.11
- WST 14.72
About ANSS ANSYS Inc.
Ansys is an engineering software company that provides simulation capabilities for structural, fluids, semiconductor power, embedded software, optical, and electromagnetic properties. Ansys employs over 4,000 people and serves over 50,000 customers globally.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.